Similarly, pathogenic variants of TP53, BRCA2, BRCA1, and RAD51D were significantly associated with early-onset breast cancer (Table 4), and pathogenic variants of TP53, BRCA2, BRCA1, and NBN were significantly associated with premenopausal breast cancer (Table 4). This evidence concerns the gene BRCA2 and breast cancer.